Robot-assisted versus conventional surgery for fragile pelvic fractures in older adults
Compares two ways of fixing pelvic fractures in older people with weak bones.
Plain-language title generated from the registry record
Registry title: Robot Assisted Minimally Invasive Treatment Versus Conventional Surgery for FFP3-4 Fragility Fractures of the Pelvis in Elderly Patients
Key facts
- Where
- Linhai, ChinaSee the site
Where in China
- No. 150 Ximen RoadLinhai, ChinaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Junbo Liang
- Trial code
- NCT07639619
- Record updated
- 10 June 2026
- Original description
This prospective randomized controlled trial aims to compare the efficacy and safety of robot assisted minimally invasive treatment versus conventional surgery in elderly patients with FFP3-4 fragility fractures of the pelvis. Eligible patients will be stratified according to FFP classification and randomly assigned in a 1:1 ratio to receive either robot assisted minimally invasive fixation or conventional surgical treatment. Primary and secondary outcomes include pain relief, early mobilization, functional recovery, perioperative complications, venous thromboembolism events, laboratory parameters, imaging outcomes, and healthcare resource utilization. The study aims to provide evidence for optimizing surgical treatment strategies in elderly patients with unstable pelvic fragility fractures.Read full original descriptionShow less
Comparing the Efficacy and Safety of Robot Assisted Minimally Invasive Treatment Versus Conventional Surgery in Elderly Patients With FFP3-4 Fragility Fractures of the Pelvis
This prospective randomized controlled trial aims to compare the efficacy and safety of robot assisted minimally invasive treatment versus conventional surgery in elderly patients with FFP3-4 fragility fractures of the pelvis. Eligible patients will be stratified according to FFP classification and randomly assigned in a 1:1 ratio to receive either robot assisted minimally invasive fixation or conventional surgical treatment. Primary and secondary outcomes include pain relief, early mobilization, functional recovery, perioperative complications, venous thromboembolism events, laboratory parameters, imaging outcomes, and healthcare resource utilization. The study aims to provide evidence for optimizing surgical treatment strategies in elderly patients with unstable pelvic fragility fractures.
Inclusion: Age ≥ 60 years; Low energy trauma; Diagnosis of osteoporosis; Diagnosis of FFP3 or FFP4 fragility fractures of the pelvis; Injury duration less than 3 weeks; Ability to provide written informed consent.
Exclusion: Hemodynamic instability preventing anesthesia or surgery; Current chemotherapy, radiotherapy, systemic corticosteroid therapy, or growth factor therapy; Severe open injury or skin infection at the surgical site; Severe psychiatric disorders or dementia; Severe systemic diseases preventing surgery; Severe obesity affecting imaging quality; Pathological fracture.